126 related articles for article (PubMed ID: 6547728)
1. Specific internalization and action of 1,25-dihydroxyvitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia.
Adams JS; Gacad MA; Singer FR
J Clin Endocrinol Metab; 1984 Sep; 59(3):556-60. PubMed ID: 6547728
[TBL] [Abstract][Full Text] [Related]
2. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.
Griffin JE; Zerwekh JE
J Clin Invest; 1983 Oct; 72(4):1190-9. PubMed ID: 6313754
[TBL] [Abstract][Full Text] [Related]
3. 1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents.
Chen TL; Hirst MA; Cone CM; Hochberg Z; Tietze HU; Feldman D
J Clin Endocrinol Metab; 1984 Sep; 59(3):383-8. PubMed ID: 6086691
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3.
Feldman D; Chen T; Cone C; Hirst M; Shani S; Benderli A; Hochberg Z
J Clin Endocrinol Metab; 1982 Nov; 55(5):1020-2. PubMed ID: 6288751
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid.
Hirst MA; Hochman HI; Feldman D
J Clin Endocrinol Metab; 1985 Mar; 60(3):490-5. PubMed ID: 2982898
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.
Gamblin GT; Liberman UA; Eil C; Downs RW; DeGrange DA; Marx SJ
J Clin Invest; 1985 Mar; 75(3):954-60. PubMed ID: 3872316
[TBL] [Abstract][Full Text] [Related]
7. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues.
Weisman Y; Jaccard N; Legum C; Spirer Z; Yedwab G; Even L; Edelstein S; Kaye AM; Hochberg Z
J Clin Endocrinol Metab; 1990 Oct; 71(4):937-43. PubMed ID: 2169482
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
Lyles KW; Drezner MK
J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
[TBL] [Abstract][Full Text] [Related]
9. Increased renal catabolism of 1,25-dihydroxyvitamin D3 in murine X-linked hypophosphatemic rickets.
Tenenhouse HS; Yip A; Jones G
J Clin Invest; 1988 Feb; 81(2):461-5. PubMed ID: 3339128
[TBL] [Abstract][Full Text] [Related]
10. Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor.
Zhu W; Malloy PJ; Delvin E; Chabot G; Feldman D
J Bone Miner Res; 1998 Feb; 13(2):259-64. PubMed ID: 9495519
[TBL] [Abstract][Full Text] [Related]
11. 25-Hydroxyvitamin D-24-hydroxylase in phytohemagglutinin-stimulated lymphocytes: intermediate bioresponse to 1,25-dihydroxyvitamin D3 of cells from parents of patients with vitamin D-dependent rickets type II.
Takeda E; Yokota I; Ito M; Kobashi H; Saijo T; Kuroda Y
J Clin Endocrinol Metab; 1990 Apr; 70(4):1068-74. PubMed ID: 2156884
[TBL] [Abstract][Full Text] [Related]
12. Increased renal 25-hydroxyvitamin D3-24-hydroxylase messenger ribonucleic acid and immunoreactive protein in phosphate-deprived Hyp mice: a mechanism for accelerated 1,25-dihydroxyvitamin D3 catabolism in X-linked hypophosphatemic rickets.
Roy S; Martel J; Ma S; Tenenhouse HS
Endocrinology; 1994 Apr; 134(4):1761-7. PubMed ID: 8137741
[TBL] [Abstract][Full Text] [Related]
13. Normal 24-hydroxylation of vitamin D metabolites in patients with vitamin D-dependency rickets type I. Structural implications for the vitamin D hydroxylases.
Mandla S; Jones G; Tenenhouse HS
J Clin Endocrinol Metab; 1992 Apr; 74(4):814-20. PubMed ID: 1548347
[TBL] [Abstract][Full Text] [Related]
14. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II.
Malloy PJ; Hochberg Z; Pike JW; Feldman D
J Clin Endocrinol Metab; 1989 Feb; 68(2):263-9. PubMed ID: 2537329
[TBL] [Abstract][Full Text] [Related]
15. Diminished internalization and action of 1,25-dihydroxyvitamin D3 in dermal fibroblasts cultured from New World primates.
Adams JS; Gacad MA; Baker AJ; Kheun G; Rude RK
Endocrinology; 1985 Jun; 116(6):2523-7. PubMed ID: 3922744
[TBL] [Abstract][Full Text] [Related]
16. Hereditary resistance to 1,25-dihydroxyvitamin D: defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone.
Liberman UA; Eil C; Holst P; Rosen JF; Marx SJ
J Clin Endocrinol Metab; 1983 Nov; 57(5):958-62. PubMed ID: 6311866
[TBL] [Abstract][Full Text] [Related]
17. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
Balsan S; Garabedian M; Liberman UA; Eil C; Bourdeau A; Guillozo H; Grimberg R; Le Deunff MJ; Lieberherr M; Guimbaud P; Broyer M; Marx SJ
J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
[TBL] [Abstract][Full Text] [Related]
18. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D.
Koren R; Ravid A; Liberman UA; Hochberg Z; Weisman Y; Novogrodsky A
J Clin Invest; 1985 Nov; 76(5):2012-5. PubMed ID: 2997300
[TBL] [Abstract][Full Text] [Related]
19. Dermal fibroblasts pretreated with a sterol Delta7-reductase inhibitor produce 25-hydroxyvitamin D3 upon UVB irradiation.
Vantieghem K; De Haes P; Bouillon R; Segaert S
J Photochem Photobiol B; 2006 Oct; 85(1):72-8. PubMed ID: 16824767
[TBL] [Abstract][Full Text] [Related]
20. Response to parathyroid hormone and 1,25-dihydroxyvitamin D3 of bone-derived cells isolated from normal children and children with abnormalities in skeletal development.
Silve C; Grosse B; Tau C; Garabedian M; Fritsch J; Delmas PD; Cournot-Witmer G; Balsan S
J Clin Endocrinol Metab; 1986 Mar; 62(3):583-90. PubMed ID: 3003145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
